|
|
|
41
|
17256
|
APO-METHYLPHENIDATE 36MG ER TAB (APO)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE
|
100'S
|
A
|
388.18
|
3.8818
|
TABER
|
42
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
RESPIRATORY-CEREBRAL STIMULANTS
|
|
|
|
|
40
|
17261
|
CONCERTA 54MG TAB (JAC/STO) METHYLPHENIDATE
|
METHYLPHENIDATE
|
CONCERTA
|
30'S
|
C
|
200.56
|
6.69
|
TABLET
|
0
|
TAB
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
17261
|
CONCERTA 54MG ER TAB (JAC) METHYLPHENIDATE (C)
|
METHYLPHENIDATE
|
CONCERTA
|
30'S
|
C
|
200.56
|
6.6853
|
TABER
|
42
|
BOTT
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
RESPIRATORY-CEREBRAL STIMULANTS
|
|
|
|
|
42
|
17261
|
CONCERTA 54MG ER TAB (JAC) METHYLPHENIDATE
|
METHYLPHENIDATE
|
CONCERTA
|
30'S
|
C
|
200.56
|
6.69
|
TABER
|
42
|
BOTT
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
282032
|
RESPIRATORY-CNS STIMULANTS
|
2026-04-01
|
|
|
ORAL
|
6
|
RESPIRATORY-CNS STIMULANTS
|
|
|
|
|
40
|
17265
|
APO-METHYLPHENIDATE ER 54MG TAB (APO/COL)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE ER
|
100'S
|
A
|
407.75
|
4.08
|
TABLET
|
30
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
17265
|
APO-METHYLPHENIDATE ER 54MG ER TAB (APO)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE ER
|
100'S
|
A
|
415.90
|
4.16
|
TAB
|
42
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
282032
|
RESPIRATORY-CNS STIMULANTS
|
2026-04-01
|
|
|
ORAL
|
6
|
RESPIRATORY-CNS STIMULANTS
|
|
|
|
|
41
|
17266
|
APO-METHYLPHENIDATE 54MG ER TAB (APO)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE
|
100'S
|
A
|
415.9
|
4.159
|
TABER
|
42
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
RESPIRATORY-CEREBRAL STIMULANTS
|
|
|
|
|
40
|
17283
|
APO-METHYLPHENIDATE SR 20MG TAB (APO/COL)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE SR
|
100'S
|
A
|
29.90
|
0.30
|
TABLET
|
60
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
17283
|
APO-METHYLPHENIDATE 20MG SR TAB (APO)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE
|
100'S
|
A
|
30.50
|
0.31
|
TAB
|
84
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
282032
|
RESPIRATORY-CNS STIMULANTS
|
2026-04-01
|
|
|
ORAL
|
6
|
RESPIRATORY-CNS STIMULANTS
|
|
|
|
|
42
|
17287
|
PMS-METHYLPHENIDATE 20MG CR CAP (PMS)
|
METHYLPHENIDATE
|
PMS-METHYLPHENIDATE
|
100'S
|
C
|
149.51
|
1.50
|
TAB
|
0
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
AVENTA BARBADOS
|
|
282032
|
RESPIRATORY-CNS STIMULANTS
|
2026-04-01
|
|
|
ORAL
|
0
|
RESPIRATORY-CNS STIMULANTS
|
|
|
|
|
41
|
1728E
|
APO-METHYLPHENIDATE 20MG SR TAB (APO)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE
|
100'S
|
A
|
30.5
|
0.305
|
TABSR
|
84
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
RESPIRATORY-CEREBRAL STIMULANTS
|
|
|
|
|
41
|
17635
|
PROMETHAZINE 25MG/ML INJ (STP) (B)
|
PROMETHAZINE
|
PROMETHAZINE
|
100X2ML
|
B
|
217.47
|
2.1747
|
AMP
|
30
|
BOX
|
STP
|
STEROP LABORATORIES
|
COL
|
COLLINS LTD
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
INJ
|
0
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCEL
|
|
|
|
|
42
|
17635
|
PROMETHAZINE 25MG/ML INJ (STP)
|
PROMETHAZINE
|
PROMETHAZINE
|
100X2ML
|
B
|
217.47
|
2.17
|
AMPG
|
30
|
BOX
|
STP
|
STEROP LABORATORIES
|
COL
|
AVENTA BARBADOS
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2026-04-01
|
|
|
IM
|
0
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCEL
|
|
|
|
|
40
|
17639
|
PROMETHAZINE 25MG/ML INJ (KWA/ATB)
|
PROMETHAZINE
|
PROMETHAZINE
|
5X2ML
|
B
|
57.08
|
11.42
|
INJECTION
|
0
|
AMP
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
IM
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
1763L
|
PROMETHAZINE 25MG/ML INJ (ROL/AHI)
|
PROMETHAZINE
|
PROMETHAZINE
|
25X1ML
|
B
|
204.04
|
8.16
|
INJECTION
|
0
|
AMP
|
ROL
|
ROXANE LABORATORIES INC.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-29
|
|
|
|
40
|
1791D
|
POLYBAR ACB 100% (EZM/COL) BARIUM SULPHATE
|
BARIUM SULPHATE
|
POLYBAR ACB
|
24X397G
|
BQ
|
1,250.43
|
52.10
|
SUSPENSION
|
0
|
KIT
|
EZM
|
E-Z-EM INC.
|
COL
|
COLLINS LTD
|
|
3668
|
ROENTGENOGRAPHY
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
DIAGNOSTIC AGENTS
|
|
|
|
|
41
|
1791D
|
POLYBAR ACB 100% (EZM) BARIUM SULPHATE
|
BARIUM SULPHATE
|
POLYBAR ACB
|
24X397G
|
BQ
|
1375.47
|
57.3113
|
KIT
|
50
|
BOX
|
EZM
|
E-Z-EM INC.
|
COL
|
COLLINS LTD
|
|
3668
|
ROENTGENOGRAPHY
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ROENTGENOGRAPHY
|
|
|
|
|
42
|
1791D
|
POLYBAR ACB 100% (EZM) BARIUM SULPHATE
|
BARIUM SULPHATE
|
POLYBAR ACB
|
24X397G
|
BQ
|
1,443.43
|
60.14
|
KIT
|
50
|
BOX
|
EZM
|
E-Z-EM INC.
|
COL
|
AVENTA BARBADOS
|
|
3668
|
ROENTGENOGRAPHY
|
2026-04-01
|
|
|
ORAL
|
0
|
ROENTGENOGRAPHY
|
|
|
|
|
40
|
1794C
|
E-Z-HD 250% SUSP (EZM/COL) BARIUM SULPHATE
|
BARIUM SULPHATE
|
E-Z-HD
|
24X340G
|
BQ
|
1,147.13
|
47.80
|
SUSPENSION
|
0
|
CUP
|
EZM
|
E-Z-EM INC.
|
COL
|
COLLINS LTD
|
|
3668
|
ROENTGENOGRAPHY
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
DIAGNOSTIC AGENTS
|
|
|
|
|
41
|
1794C
|
E-Z-HD 250% SUSP (EZM) BARIUM SULPHATE
|
BARIUM SULPHATE
|
E-Z-HD
|
24X340G
|
BQ
|
1261.3
|
52.5543
|
CUP
|
0
|
BOX
|
EZM
|
E-Z-EM INC.
|
COL
|
COLLINS LTD
|
|
3668
|
ROENTGENOGRAPHY
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ROENTGENOGRAPHY
|
|